Aptose Biosciences Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q1 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Aptose Biosciences Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q1 2018 to Q4 2023.
  • Aptose Biosciences Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending December 31, 2023 was $198K.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $198K Dec 31, 2023 10-K 2024-03-26
Q3 2023 $197K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $197K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $197K Mar 31, 2023 10-Q 2023-05-08
Q4 2020 $119K -$344K -74.3% Dec 31, 2020 10-K 2021-03-23
Q3 2020 $119K -$426K -78.2% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $119K -$413K -77.6% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $463K -$69K -13% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $463K -$11K -2.32% Dec 31, 2019 10-K 2020-03-10
Q3 2019 $545K +$81K +17.5% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $532K +$255K +92.1% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $532K +$255K +92.1% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $474K Dec 31, 2018 10-K 2019-03-12
Q3 2018 $464K Sep 30, 2018 8-K 2019-03-12
Q2 2018 $277K Jun 30, 2018 8-K 2019-03-12
Q1 2018 $277K Mar 31, 2018 8-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.